Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 24 July 2016

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Barrett's esophagus and esophageal cancer is levelling off in Europe

Barrett's esophagus and esophageal adenocarcinoma in the United Kingdom and the Netherlands is levelling off, reports the latest issue of the Alimentary Pharmacology & Therapeutics.

News image

Barrett's esophagus is a risk factor for esophageal adenocarcinoma.

Several studies report increasing incidences of Barrett's esophagus with substantial variation.

Dr Masclee and colleagues from the Netherlands determined age- and sex-stratified incidence rates of Barrett's esophagus and esophageal adenocarcinoma.

The team performed a cohort study using 2 primary care databases in the United Kingdom and the Netherlands.

Barrett's esophagus and esophageal adenocarcinoma cases were identified using disease-specific READ codes, and free-text search with manual validation.

Age- and sex-specific incidence rates were calculated for both Barrett's esophagus and esophageal adenocarcinoma.
Incident rates of Barrett's was 24 times higher in males across all age groups
Alimentary Pharmacology & Therapeutics

From the study population of 6,885,420 subjects in the UK, the team identified 12,312 incident Barrett's esophagus, and 40 subsequent incident esophageal adenocarcinoma cases.

There were 1383 incident Barrett's esophagus, and subsequent 5 incident esophageal adenocarcinoma cases among the 1,487,191 subjects in the Netherlands.

The team found that the incident rate of Barrett's esophagus increased linearly with age, and was 16 per 100,000 PYs in the United Kingdom, and 24 per 100,000 PYs in the Netherlands for patients aged 4044 years, increasing to 86 per 100,000 PYs in the United Kingdom, and 87 per 100,000 PYs in the Netherlands for 7074 years.

In both the United Kingdom and the Netherlands, incident rates of Barrett's esophagus was 24 times higher in males than females across all age groups.

The team observed that with respect to calendar time, the incident rate of Barrett's esophagus increased by 35% in the United Kingdom, and 41% in the Netherlands from 2000 to 2003, after which incident rates remained stable until 2012.

Dr Masclee's team concludes, "The incidence rates of Barrett's esophagus in the United Kingdom and the Netherlands increased until 2003, but levelled off thereafter."

"Around 0.3% of patients with Barrett's esophagus developed esophageal adenocarcinoma at least 1 year after Barrett's esophagus diagnosis. "

"These findings may help tailor endoscopic surveillance strategies among patients with Barrett's esophagus."

Aliment Pharmacol Ther 2014: 39(11): 13211330
22 May 2014

Go to top of page Email this page Email this page to a colleague

 22 July 2016 
Fecal calprotectin and IBD
 22 July 2016 
Duodenal villous atrophy and celiac disease
 22 July 2016 
Upper GI lesions at primary diagnosis in IBD
 21 July 2016 
Radiofrequency ablation in Barrett's
 21 July 2016 
HCV eradication and inflammation in cirrhotic patients
 21 July 2016 
Surveillance of Barrett's
 20 July 2016 
Nonselective β-blockers and survival in cirrhosis
 20 July 2016 
Adolescent body mass index and and colorectal cancer risk
 20 July 2016 
Genetic biomarkers and IBD treatment response
 19 July 2016 
Prevention of chemotherapy-induced nausea and vomiting
 19 July 2016 
Longterm clinical follow-up of living liver donors
 19 July 2016 
Screening diabetic patients for NAFLD
 18 July 2016 
Rectal neuroendocrine tumors
 18 July 2016 
Liver stiffness measurement in chronic liver disease
 18 July 2016 
Liver cancer prediction scores in Hep B
 15 July 2016 
Patient reported outcomes in celiac disease
 15 July 2016 
Tonsillectomy and IBD risk
 15 July 2016 
Trainee IBD education in the USA
 14 July 2016 
Screening for familial pancreatic cancer
 14 July 2016 
Fecal calprotection for IBD prognosis
 14 July 2016 
Perianal surgery risk in Crohn's
 13 July 2016 
Lung transplant outcomes in Hep C
 13 July 2016 
Psychological comorbidity and postinfectious IBS
 13 July 2016 
Graft selection strategy in living donor liver transplants
 12 July 2016 
Treatment of pediatric acute liver failure
 12 July 2016 
Therapy for iron deficiency anemia in IBD
 12 July 2016 
Surveillance endoscopy in Barrett's esophagus
 11 July 2016 
Disturbed sleep and IBS
 11 July 2016 
Transition to adulthood in celiac disease
 11 July 2016 
Factors that influence access to liver transplant
 08 July 2016 
Mortality and peptic ulcers
 08 July 2016 
Statins and cirrhosis in Hep B
 08 July 2016 
Genetic risk score and body mass index
 07 July 2016 
Predicting food triggers in eosinophilic esophagitis
 07 July 2016 
Extraperitoneal vs transperitoneal colostomy for hernia
 07 July 2016 
Predictors fecal transplant failure in C. diff infection
 06 July 2016 
Therapies for Hep B cure
 06 July 2016 
Hospital volume and liver cancer survival
 06 July 2016 
Adverse events after outpatient colonoscopy
 05 July 2016 
Colorectal surgery and dialysis
 05 July 2016 
Non-invasive scoring systems for fibrosis in NAFLD
 05 July 2016 
Exercise and gastroesophageal reflux
 04 July 2016 
Guidelines on PPI and NSAID prescription
 04 July 2016 
Rectal cancer surgery checklist
 04 July 2016 
Autoimmunity in eosinophilic esophagitis and families
 01 July 2016 
Outcome measures in celiac disease
 01 July 2016 
Growth factor activity and IBD
 01 July 2016 
Aspirin and colorectal cancer
 30 June 2016 
Staging system for familial adenomatous polyposis
 30 June 2016 
Antibiotics in children and obesity
 30 June 2016 
IBS-type symptoms in pediatric IBD
 29 June 2016 
Hep C eradication in people who inject drugs
 29 June 2016 
Anti-tumor necrosis factor in mothers and newborns
 29 June 2016 
Progression to esophageal carcinoma in Barrett's
 28 June 2016 
Gastric cancer screening in the USA
 28 June 2016 
Cancer recurrence after immune-suppressive therapies
 28 June 2016 
Acute severe ulcerative colitis
 27 June 2016 
Tobacco smoking and ulcerative colitis
 27 June 2016 
Epidemiology of NAFLD
 27 June 2016 
The Toronto Consensus for H. pylori treatment

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2016 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us